semaglutide for prediabetes RCT: In patients with #schizophrenia, #prediabetes, and #obesity, once-weekly #semaglutide injections, up to 1.0 mg/week, were safe and effective. https://t.co/u7CwGLDs1E Pre-diabetes rates increase amidst a
Description
MEDI0382, A GLP-1/Glucagon Receptor Dual Agonist, Meets Safety and Tolerability Endpoints in a Single-Dose, Healthy-Subject, Randomized, Phase 1 Study
Currently, Retatrutide is not FDA-approved for human use and can only be studied in lab environments and for research purposes
Theyre very effective in helping people with type 2 diabetes achieve their glycemic goals
Our guide on supplements to take with GLP-1 medications covers this topic in detail
The test should be interpreted as part of a comprehensive assessment, not a replacement for clinical evaluation
